BioLife Solutions, Inc.

The current price of BLFS is $38.61 — it has remained unchanged since the previous close. Data as of Oct 5, 2026.

BLFS is flat over the past week, flat over the past month and up 42.42% over the past year. The price is above its 200-day moving average of $26.62.

Analysts' average 12-month price target for BLFS is $31.00, which implies 19.71% downside from the current price. Individual estimates range from $31.00 to $31.00.

Of the 9 analysts covering BioLife Solutions, Inc., 1 rates it a buy and 8 rate it a hold. The overall consensus is neutral. Analyst ratings are opinions and do not guarantee future performance.

BioLife Solutions, Inc. has a market capitalization of $1.89B. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.

In its most recent quarterly report, BioLife Solutions, Inc. posted earnings of $0.91 per share against an estimate of $0.03125, beating expectations by 2,812.00%. Upcoming reports are listed in the earnings calendar.

BioLife Solutions, Inc. reported revenue of $28.47M in its most recent quarter, which has increased by 11.98% compared with the same quarter a year earlier. Analysts had expected $27.8M.

BioLife Solutions, Inc. has not paid any dividends over the past year.

Companies most comparable to BioLife Solutions, Inc. include West Pharmaceutical Services, Inc., Bio-Techne Corporation, Repligen Corporation, Azenta, Inc. and Maravai LifeSciences Holdings, Inc.

In the latest trading session BLFS moved between $37.00 and $38.83, a range of 4.74% of its current price.

Investing in stocks requires thorough research: study the company's financials, related news and technical analysis before making a decision. Technical analysis of BioLife Solutions, Inc. shows a buy rating today and a strong buy rating on the weekly timeframe. Technical ratings are indicators, not investment advice.

Over the past 52 weeks BLFS has traded between $17.86 and $39.76. The current price is 2.89% below its 52-week high.